April 2025
Four Lane Enterprises Ltd
Adviser to Four Lane Enterprises Ltd on their sale to Vespa Capital
£undisclosed
Grant Thornton team
Private sector healthcare
Sell side
Corporate finance
Flag of the United Kingdom

We are delighted to have advised on the sale of FibroFind to Vespa Capital

FibroFind is a globally recognised, award-winning pre-clinical contract research organisation (CRO) which has revolutionised drug testing and pre-clinical research in human tissue testing. FibroFind’s management team offers world-leading expertise in their field to blue-chip clients across the globe. 

FibroFind appointed our Corporate Finance team to assist in finding a strategic partner and support its growth ambitions. 

Our experience in the Life Sciences and Pharma industry enabled us to provide specialised sector expertise and insight to support a highly complex business founded on globally renowned capabilities. 

Our Corporate Finance team ran a competitive process, garnering interest from both trade and private equity to deliver the best possible outcome for our client as they sought to gain a strategic partner for the next phase of their impressive growth journey. 

We provided hands-on support throughout the transaction, managing various deal streams and shareholder interests to produce an excellent outcome for all involved. 

“The Grant Thornton team were nothing short of phenomenal. Their strategic brilliance, deep sector expertise and relentless commitment delivered a result beyond our highest expectations. They did not just advise us — they championed our vision, navigated complexity with ease and secured the perfect partner for our next chapter.”
Jelena Mann Co-Founder and CEO, FibroFind